In its appeal from an adverse decision on priority by the Patent Trial and Appeal Board (PTAB) in Interference No. 106,115 (directed to CRISPR-mediated gene editing), Junior Party the.
In Dionex Softron GmbH v. Agilent Technologies, Inc., Nos. 21-1794 and 21-2372, the Court of Appeals for the Federal Circuit ("the Federal Circuit") affirmed interference decisions.
The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board’s interference decision finding that priority belonged to the junior party based on sufficiently corroborated reduction to practice. Dionex Softron GmbH v. Agilent Technologies Inc.
A new year means new Federal Circuit decisions to analyze. Our case of the week recounts an interesting saga of companies copying each other's patent applications to provoke an interference.
A new year means new Federal Circuit decisions to analyze. Our case of the week recounts an interesting saga of companies copying each other’s patent applications to provoke an.